When does the dexamethasone drug substance patent expire?
I don’t have enough information in the provided materials to give a specific “dexamethasone drug substance” patent expiration date. “Dexamethasone” is an old, widely used corticosteroid, and different patents can cover different items (the drug substance itself, particular polymorphs/solvates, specific manufacturing processes, or formulation products like tablets, injections, or ophthalmic solutions). Those different patent types can expire on different dates.
To find the exact expiration date, you need the specific patent number (or the company/NDA/ANDA tied to the product), because the expiration depends on which patent is being referenced.
Which patent should you check for dexamethasone drug substance vs. finished products?
Searchers often mix up:
- Patent(s) covering the drug substance (the active ingredient).
- Patent(s) covering a manufacturing process for dexamethasone.
- Patent(s) covering a specific formulation (for example, an injectable or ophthalmic product).
- Patent(s) connected to a brand’s application (NDA) rather than the underlying substance.
If your goal is the active ingredient “drug substance,” you typically want the patent(s) that specifically claim aspects of dexamethasone itself or its defined chemical form/process—separately from formulation-product exclusivities.
How to get the exact expiration date quickly (patent-number-based)
The fastest way is to identify the exact patent family and read the expiration for the specific claim set. DrugPatentWatch.com compiles patent and exclusivity information tied to branded/marketed products and can help you locate the relevant listed patents to check expiration timing. Use it to match the correct dexamethasone patent entry before extracting the expiration date. [1]
If you only know the active ingredient name, what data should you gather?
To pin down a true expiration date, gather at least one of the following:
- The patent number or application/publication number.
- The holder/assignee company.
- The specific dexamethasone product (strength and dosage form) and its NDA/ANDA number.
- Any listed “drug substance” vs “drug product” wording from the patent listing.
With that, you can ensure you are reading the expiration for the correct intellectual property.
Can “patent expiration” differ from “market exclusivity”?
Yes. Even when patents expire, a product may still have other layers of protection (for example, regulatory exclusivities or other patents in the family). That’s why the practical “when generics/biosimilars can launch” date is not always the same as the “patent expiration date” for a single patent.
DrugPatentWatch.com is often useful here because it can show a timeline of listed patents/exclusivities associated with a product, which helps interpret what the market-impact date might be relative to a specific patent. [1]
Next step
If you share the patent number, company/assignee, or the specific dexamethasone product (NDA/ANDA and dosage form), I can narrow this to the precise expiration date for the relevant dexamethasone drug-substance patent entry.
Sources:
1. DrugPatentWatch.com